Pharmacology

43
Pharmacology CRT 11? = 8% RRT 6?

description

Pharmacology. CRT 11? = 8% RRT 6?. - PowerPoint PPT Presentation

Transcript of Pharmacology

Page 1: Pharmacology

Pharmacology

CRT 11? = 8%

RRT 6?

Page 2: Pharmacology

A 30-year-old patient presents to the asthma clinic with a 2-week history of daily wheezing and nightly awakenings with shortness of breath. The patient is using Primatene Mist five times daily and fluticasone propionate (Flovent) 110 MDI occassionally at night. How should the therapist counsel the patient regarding disease management?   

I. Discontinue Primatene Mist II. Use fluticasone propionate (Flovent) 110 MDI, 2 puffs twice

daily.III. Use salmeterol (Serevent) dry powder inhaler, 1 dose twice

daily.IV. Use fluticasone propionate/salmeterol (Advair) 100/50 dry

powder inhaler, one dose daily.

A. I, II, and III only B. I, II, and IV only C. I, III, and IV only D. II, III, and IV only

Page 3: Pharmacology

A 30-year-old patient presents to the asthma clinic with a 2-week history of daily wheezing and nightly awakenings with shortness of breath. The patient is using Primatene Mist five times daily and fluticasone propionate (Flovent) 110 MDI occassionally at night. How should the therapist counsel the patient regarding disease management?   

I. Discontinue Primatene Mist II. Use fluticasone propionate (Flovent) 110 MDI, 2 puffs twice

daily.III. Use salmeterol (Serevent) dry powder inhaler, 1 dose twice

daily.IV. Use fluticasone propionate/salmeterol (Advair) 100/50 dry

powder inhaler, one dose daily.

A. I, II, and III only B. I, II, and IV only C. I, III, and IV only D. II, III, and IV only

Page 4: Pharmacology

Which of the following is associated with the administration of aerosolized pentamidine isethionate (NebuPent)?

A.tachycardia B.bradycardia C.bronchospasm D.hypotension

Page 5: Pharmacology

Which of the following is associated with the administration of aerosolized pentamidine isethionate (NebuPent)?

A.tachycardia B.bradycardia C.bronchospasm D.hypotension

Page 6: Pharmacology

An increase in a patient's heart rate during aerosolized bronchodilator therapy is primarily a result of which of the following drug effects?

A.alpha only B.beta 1 only C.beta 2 only D.beta 1 and beta 2 only

Page 7: Pharmacology

An increase in a patient's heart rate during aerosolized bronchodilator therapy is primarily a result of which of the following drug effects?

A.alpha only B.beta 1 only C.beta 2 only D.beta 1 and beta 2 only

Page 8: Pharmacology

Which of the following devices are most commonly used to deliver aerosols by the inhalation route?

I. Dry powder inhalerII. Metered dose inhalerIII. Small-volume nebulizerIV.Slip-stream nebulizer

A. I and IIIB. II and IVC. I, II, and IIID. I, II, III, and IV

Page 9: Pharmacology

Which of the following devices are most commonly used to deliver aerosols by the inhalation route?

I. Dry powder inhalerII. Metered dose inhalerIII. Small-volume nebulizerIV.Slip-stream nebulizer

A. I and IIIB. II and IVC. I, II, and IIID. I, II, III, and IV

Page 10: Pharmacology

Which of the following are the largest single group of drugs among aerosolized agents used for inhalation?A. Inhaled corticosteroidsB. Adrenergic bronchodilatorsC. Mucus-controlling agentsD. Anticholinergic bronchodilators

Page 11: Pharmacology

Which of the following are the largest single group of drugs among aerosolized agents used for inhalation?A. Inhaled corticosteroidsB. Adrenergic bronchodilatorsC. Mucus-controlling agentsD. Anticholinergic bronchodilators

Page 12: Pharmacology

Which of the following is an indication for use of an adrenergic bronchodilator?

A.Treatment of excessive, viscous mucus secretions

B.Antiinflammatory treatment of mild to moderate persistent asthma

C.Treatment of reversible airflow obstructionD.Prophylactic management of asthma

Page 13: Pharmacology

Which of the following is an indication for use of an adrenergic bronchodilator?

A.Treatment of excessive, viscous mucus secretions

B.Antiinflammatory treatment of mild to moderate persistent asthma

C.Treatment of reversible airflow obstructionD.Prophylactic management of asthma

Page 14: Pharmacology

Proventil and Ventolin are brand names for which of the following beta-adrenergic bronchodilators?A. AlbuterolB. IsoetharineC. TerbutalineD. Metaproterenol

Page 15: Pharmacology

Proventil and Ventolin are brand names for which of the following beta-adrenergic bronchodilators?A. AlbuterolB. IsoetharineC. TerbutalineD. Metaproterenol

Page 16: Pharmacology

An MDI of Salmeterol delivers which of the following?A. 131 mg/puffB. 90 mg/puffC. 65 mg/puffD. 25 mg/puff

Page 17: Pharmacology

An MDI of Salmeterol delivers which of the following?A. 131 mg/puffB. 90 mg/puffC. 65 mg/puffD. 25 mg/puff

Page 18: Pharmacology

Which of the following short-acting catecholamines are used for their strong alpha1 vasoconstricting effects to reduce swelling in the nose and larynx and to control bleeding during bronchoscopic biopsy?A. IsoproterenolB. IsoetharineC. DobutamineD. Racemic epinephrine

Page 19: Pharmacology

Which of the following short-acting catecholamines are used for their strong alpha1 vasoconstricting effects to reduce swelling in the nose and larynx and to control bleeding during bronchoscopic biopsy?A. IsoproterenolB. IsoetharineC. DobutamineD. Racemic epinephrine

Page 20: Pharmacology

Which of the following are side effects of newer, more beta2-selective bronchodilators?A. TremorB. InsomniaC. NervousnessD. All the above

Page 21: Pharmacology

Which of the following are side effects of newer, more beta2-selective bronchodilators?A. TremorB. InsomniaC. NervousnessD. All the above

Page 22: Pharmacology

What are some potential adverse effects with use of adrenergic bronchodilators?

I. HypokalemiaII. DizzinessIII. Worsening ventilation/perfusion ratio (V/Q)IV.Bradycardia

A. I and IV onlyB. II and III onlyC. I, II, and IIID. I, II, III, and IV

Page 23: Pharmacology

What are some potential adverse effects with use of adrenergic bronchodilators?

I. HypokalemiaII. DizzinessIII. Worsening ventilation/perfusion ratio (V/Q)IV.Bradycardia

A. I and IV onlyB. II and III onlyC. I, II, and IIID. I, II, III, and IV

Page 24: Pharmacology

Which of the following are assessment features for evaluating patient response to bronchodilator therapy?

I. Reversibility of airflow obstructionII. Changes in flow rates using a peak flow meter or

portable spirometryIII. Vital-sign changes (e.g., blood pressure, pulse rate)IV. Changes in ventilation and oxygenation by arterial

blood gas or pulse oximeterV. The patient's subjective reaction to treatment

A. II, III, and IVB. II, III, and VC. I, II, III, and VD. I, II, III, IV, and V

Page 25: Pharmacology

Which of the following are assessment features for evaluating patient response to bronchodilator therapy?

I. Reversibility of airflow obstructionII. Changes in flow rates using a peak flow meter or

portable spirometryIII. Vital-sign changes (e.g., blood pressure, pulse rate)IV. Changes in ventilation and oxygenation by arterial

blood gas or pulse oximeterV. The patient's subjective reaction to treatment

A. II, III, and IVB. II, III, and VC. I, II, III, and VD. I, II, III, IV, and V

Page 26: Pharmacology

What amount of Ipratropium bromide (Atrovent) is delivered by MDI?A. 10 mg/puffB. 15 mg/puffC. 18 mg/puffD. 90 mg/puff

Page 27: Pharmacology

What amount of Ipratropium bromide (Atrovent) is delivered by MDI?A. 10 mg/puffB. 15 mg/puffC. 18 mg/puffD. 90 mg/puff

Page 28: Pharmacology

What is the dosage for Ipratropium bromide (Atrovent)?A. 2 puffs qidB. 2 puffs tidC. 2 puffs bidD. 2 puffs q12h

Page 29: Pharmacology

What is the dosage for Ipratropium bromide (Atrovent)?A. 2 puffs qidB. 2 puffs tidC. 2 puffs bidD. 2 puffs q12h

Page 30: Pharmacology

What are some common side effects seen with Ipratropium bromide (Atrovent)?A. TachycardiaB. Blood pressure increaseC. Cough and dry mouthD. Tolerance

Page 31: Pharmacology

What are some common side effects seen with Ipratropium bromide (Atrovent)?A. TachycardiaB. Blood pressure increaseC. Cough and dry mouthD. Tolerance

Page 32: Pharmacology

Which of the following are indications for use of acetylcysteine (Mucomyst)?

I. Treatment of acetaminophen overdoseII. Treatment of excessive, viscous mucus

secretionsIII. Treatment of aspirin overdoseIV.Treatment of purulent mucus secretions by

breaking up DNA

A. I and II onlyB. II and IV onlyC. I, II, and IIID. I, II, III, and IV

Page 33: Pharmacology

Which of the following are indications for use of acetylcysteine (Mucomyst)?

I. Treatment of acetaminophen overdoseII. Treatment of excessive, viscous mucus

secretionsIII. Treatment of aspirin overdoseIV.Treatment of purulent mucus secretions by

breaking up DNA

A. I and II onlyB. II and IV onlyC. I, II, and IIID. I, II, III, and IV

Page 34: Pharmacology

Acetylcysteine (Mucomyst) lowers the viscosity of mucus by means of which of the following?

A.Breaking down DNAB.Increasing the osmolarity of the mucus and

pulling water into itC.Changing the pH of the mucus, causing it to

break downD.Substituting its sulfhydryl group for disulfide

bonds and breaking a portion of the bond forming the gel structure

Page 35: Pharmacology

Acetylcysteine (Mucomyst) lowers the viscosity of mucus by means of which of the following?

A.Breaking down DNAB.Increasing the osmolarity of the mucus and

pulling water into itC.Changing the pH of the mucus, causing it to

break downD.Substituting its sulfhydryl group for disulfide

bonds and breaking a portion of the bond forming the gel structure

Page 36: Pharmacology

Which of the following should be assessed when delivering acetylcysteine (Mucomyst)?

I. Presence of adverse effects that require treatment to be discontinued

II. Monitoring peak flow changesIII. Monitoring color, consistency, and amount of sputumIV. Monitoring for presence of hydrogen sulfide (a rotten

egg odor), which means that the acetylcysteine (Mucomyst) is no longer active

A. I and III onlyB. I, II, and IIIC. II, III, and IVD. I, II, III, and IV

Page 37: Pharmacology

Which of the following should be assessed when delivering acetylcysteine (Mucomyst)?

I. Presence of adverse effects that require treatment to be discontinued

II. Monitoring peak flow changesIII. Monitoring color, consistency, and amount of sputumIV. Monitoring for presence of hydrogen sulfide (a rotten

egg odor), which means that the acetylcysteine (Mucomyst) is no longer active

A. I and III onlyB. I, II, and IIIC. II, III, and IVD. I, II, III, and IV

Page 38: Pharmacology

Which of the following are true regarding glucocorticoids?

I. They work through activation of intracellular receptors.

II. Relief is immediate.III. Daily compliance is essential to controlling

inflammation in asthma.IV.Taken intranasally they can control allergic and

nonallergic rhinitis.A. I, II, and IIIB. I, III, and IVC. II, III, and IVD. I, II, III, and IV

Page 39: Pharmacology

Which of the following are true regarding glucocorticoids?

I. They work through activation of intracellular receptors.

II. Relief is immediate.III. Daily compliance is essential to controlling

inflammation in asthma.IV.Taken intranasally they can control allergic and

nonallergic rhinitis.A. I, II, and IIIB. I, III, and IVC. II, III, and IVD. I, II, III, and IV

Page 40: Pharmacology

How does cromolyn sodium work?A.Producing antiinflammatory enzymes within

cellsB.Inhibiting degranulation of mast cellsC.Preventing arachidonic acid formation from

activation of mast cell membrane phospholipase A2

D.Leukotriene inhibition

Page 41: Pharmacology

How does cromolyn sodium work?A.Producing antiinflammatory enzymes within

cellsB.Inhibiting degranulation of mast cellsC.Preventing arachidonic acid formation from

activation of mast cell membrane phospholipase A2

D.Leukotriene inhibition

Page 42: Pharmacology

Which of the following is true about the use of Ribavirin?

I. It is used as an antiviral agent against influenza.II. It is delivered by a SPAG unit.III. Adverse effects include skin rash, conjunctivitis,

and eyelid erythema.IV.It can occlude endotracheal-tube and ventilator

exhalation valves.

A. I, and II onlyB. III and IV onlyC. II, III, and IVD. I, II, III, and IV

Page 43: Pharmacology

Which of the following is true about the use of Ribavirin?

I. It is used as an antiviral agent against influenza.II. It is delivered by a SPAG unit.III. Adverse effects include skin rash, conjunctivitis,

and eyelid erythema.IV.It can occlude endotracheal-tube and ventilator

exhalation valves.

A. I, and II onlyB. III and IV onlyC. II, III, and IVD. I, II, III, and IV